APOE gene polymorphisms associated with down syndrome in colombian populations;Polimorfismos del gen apoe en individuos con síndrome de down y sus progenitores en una población colombiana

Biomedica

Volumn 32, Issue 2, 2012, Pages 224-232

  Rengifo, Lucero ^a   Gaviria, Duverney ^a   Serrano, Herman ^a  

^a UNIVERSIDAD TECNOLÓGICA DE PEREIRA   (Colombia)

Author keywords

Alleles; Alzheimer's disease; Apolipoprotein E; Colombia; Down syndrome; Genotype

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4;

ADOLESCENT; ADULT; ALLELE; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CHILD; COLOMBIA; DOWN SYNDROME; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; INFANT; MALE; MIDDLE AGED; NEWBORN; PARENT; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLOMBIA; DOWN SYNDROME; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PARENTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; YOUNG ADULT;

EID: 84870030360     PISSN: 01204157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Sherman SL, Allen MG, Bean LH, Freeman SB.Epidemiology of Down syndrome. Ment Retard Dev D R.2007;13:221-7.
2. Allen EG, Freeman SB, Druschel C, Hobbs CA, O'Leary LA, Romitti PA, et al. Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjuntion:A report from the Atlanta and National Down Syndrome Projects. Hum Genet. 2009;125:41-2.
3. Antonarakis SE, Petersen MB, McInnis MG, Adelsberger PA, Schinzel AA, Binkert F, et al. The meiotic stage of nondisjunction in trisomy 21: Determination by using DNA polymorphisms. Am J Hum Genet. 1992;50:544-50.
4. Sherman SL, Petersen MB, Freeman SB, Hersey J, Pettay D, Taft M, et al. Non-disjunction of chromosome 21 in maternal meiosis I: Evidence for a maternal agedependent mechanism involving reduced recombination.Hum Mol Genet. 1994;3:1529-35.
5. Petersen MB, Mikkelsen M. Nondisjuntion in trisomy 21:Origin and mechanism. Cytogenet Cell Genet. 2000;91:199-203.
6. Malini SS, Ramachandra NB. Influence of advanced age of maternal grandmothers on Down syndrome. BMC Med Genet. 2006;7:1-5.
7. Dupuy AM, Mas E, Ritchie K, Descomps B, Badiou S, Cristol JP, et al. The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease.Gerontology. 2001;47:213-8.
8. Tyrrell J, Cosgrave M, McCarron M, McPherson J, Calvert J, Kelly A, et al. Dementia in people with Down's syndrome. Int J Geriatr Psychiat. 2001;16:1168-74.
9. Patel A, Rees SD, Kelly MA, Bain SC, Barnett AH, Thalitaya D, et al. Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alz heimer's disease in subjects with Down syndrome.Neurosci Lett. 2011;487:144-8.
10. Visser FE, Aldenkamp AP, van Huffelen AC, Kuilman M, Overweg J, van Wijk J. Prospective study of the prevalence of Alzheimer type dementia in institutionalize d individuals with Down syndrome. Am J Ment Retard. 1997;101:400-12.
11. Chu SH, Roeder K, Ferrell RE, Devlin B, DeMichele-Sweet MA, Kamboh MI et al. TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer diseas e. Neurobiol Aging. 2011;32:2328:e1-9.
12. Seripa D, Matera MG, Daniele A, Bizzarro A, Rinaldi MC, Gravina L, et al. The missing ApoE allele. Ann Hum Genet.2007;71:496-500.
13. Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, et al. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. BMC Neurol. 2008;8:1-7.
14. Khachaturian AS, Corcoran CD, Mayer LS, Zandi PP, Breitner JC. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susc eptibility:The Cache County Study. Arch Gen Psychiat. 2004;5:518-24.
15. Corder A, Saunders W, Strittmatter D, Schmechel P, Gaskell G, Small G, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-3.
16. Jacquier M, Villareal E, Torres O, Serrano ML, Cruts M, Montañes P, et al. APOE epsilon4 and Alzheimer's disease: Positive association in a Colombian clinical seriesand review of the Latin-American studies. Arq Neuropsiquiatr.2001;59:11-7.
17. Huang Y. Apolipoprotein E and Alzheimer disease.Neurology. 2006;66(Suppl.1):S79-85.
18. Verghese PB, Castellano JM, Holtzman DM. Apoliprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 2011;10:241-52.
19. Arboleda GH, Yunis JJ, Pardo R, Gómez CM, Hedmont D, Arango G, et al. Apolipoprotein E genotyping in a sample of Colombian patients with Alzheimeŕs disease.Neurosci Lett. 2001;135-8.
20. Corder E, Saunders A, Risch M, Strittmatter W, Schmechel D, Gaskell P, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180-4.
21. Trachtenberg AJ, Filippini N, Cheeseman J, Duff EP, Neville MJ, Ebmeier KP, et al. The effects of APOE on brain activity do no simply reflect the risk of Alzheimer's disease. Neurobiol Aging. 2012;618:e1-13.
22. Coppus AM, Evenhuis HM, Verberne GJ, Visser FE, Vásquez AA, Sayed-Tabatabaei F, et al. The impact of apolipoprotein E on dementia in persons with Down's syndrome. Neurobiol Aging. 2008;29:828-35.
23. Tyrell j, Cosgrave M, Hawi Z, McPherson J, O'Brien C, McCalvert J, et al. A protective effect of apolipoprotein E e2 allele on dementia in Down's syndrome. Biol Psychiatry.1998;43:397-400.
24. Prasher VP, Sajith SG, Rees SD, Patel A, Tewari S, Schupf N, et al. Significant effect of APOE epsilon 4 genotype on the risk of dementia in Alzheimer's disease and mortality in persons with Down syndrome. Int J Geriatr Psychiatry.2008;11:1134-40.
25. Alexander GE, Saunders AM, Szczepanik J, Strassburger TL, Pietrini P, Danni A, et al. Relation of age and apolipoprotein E to cognitive function in Down syndrome adults. Neuroreport. 1997;8:1835-40.
26. Zigman WB, Jenkins EC, Tycko B, Schupf N, Silverman W. Mortality is associated with apolipoprotein E epsilon4 in non demented adults with Down syndrome. Neurosci Lett.2005;390:93-7.
27. Schupf N, Sergievsky GH. Genetic and host factors for dementia in Down's syndrome. Br J Psychiatry 2002;180:405-10.
28. Lai F, Kammann E, Rebeck GW, Anderson A, Chen Y, Nixon RA. APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome. Neurology.1999;53:331-6.
29. Prasher VP Chowdhury T, Rowe B, Bain S. ApoE genotype and Alzheimer's disease in adults with Down syndrome: Meta-analysis. Am J Ment Retard. 1997;102:103-10.
30. Anello G, Guéant J, Romano C, Barone C, Pettinato R, Pillot T, et al. Allele e4 of apolipoprotein E gene is less frequent in Down syndrome patients of the Sicilian population and has no influence on the grade of mental retardation. Neurosci Lett. 2001;306:129-1.
31. Lambert JC, Tur JP, Duperi MJ, Delacourte A, Frigard B, Chatier-Harlim MC. Analysis of the APOE alleles impact in Dowńs syndrome. Neurosci Lett. 1996; 220:57-60.
32. Schupf N, Kapell D, Lee J, Ottman R, Mayeus R. Increased risk of Alzheimeŕs disease in mothers of adults with Dowńs syndrome. Lancet 1994;344: 353-6.
33. Avramopoulos D, Mikkelsen M, Vassilopoulos D, Grigoriadou M, Petersen M. Apolipoprotein E allele distribution in parents of Down's syndrome children. Lancet.1996;347:862-5.
34. Rodríguez J, Cediel V. Genotipificación de apolipoproteína E en la población de Risaralda. Rev Med Risaralda. 1999;5:2-7.
35. Hixon J, Vernier V. Restriction isotyping of human apolipoporotien E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31:545-8.
36. Deb S, Braganza J, Norton N, Williams H, Kehoe PG, Williams J, et al. ApoE e4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome. Br J Psychiatry. 2000;176:468-72.
37. van Gool WA, Evenhuis HM, van Duijn CM. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch StudyGroup on Down's Syndrome and Ageing. Ann Neurol. 1995;38:225-30.
38. Jaramillo-Correa JP, Keyeux G, Ruiz-García M, Rodas C, Bernal J. Population genetic análisis of the genes APOE, APOB (3́VNTR) and ACE in some black and Amerindian communities from Colombia. Hum Hered. 2001;52:14-33.